Old Web
English
Sign In
Acemap
>
authorDetail
>
Miklós Szabó
Miklós Szabó
Randox Laboratories Ltd
Immunology
Medicine
Biochemistry
Biology
Ipilimumab
5
Papers
47
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Interesting possibilities to improve the safety of ipilimumab.
2017
Journal of Clinical Oncology
Tibor Bakács
Ralph W. Moss
Jitendra N. Mehrishi
Miklós Szabó
Show All
Source
Cite
Save
Citations (0)
Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy)
2012
Pharmacological Research
Tibor Bakács
Jitendra N. Mehrishi
Miklós Szabó
Ralph W. Moss
Show All
Source
Cite
Save
Citations (12)
T Cells Survey the Stability of the Self: A Testable Hypothesis on the Homeostatic Role of TCR-MHC Interactions
2007
International Archives of Allergy and Immunology
Tibor Bakács
Jitendra N. Mehrishi
Tamás Szabados
Laszlo Varga
Miklós Szabó
Gábor Tusnády
Show All
Source
Cite
Save
Citations (12)
Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials
2007
Vaccine
Jitendra N. Mehrishi
Miklós Szabó
Tibor Bakács
Show All
Source
Cite
Save
Citations (23)
Micromolar A and B Blood Group Active Trisaccharides Abolish Human Complement Haemolytic Activity Assayed by Erythrocytes
2003
International Archives of Allergy and Immunology
Tibor Bakács
Miklós Szabó
Laszlo Varga
Rosey Mushens
Jitendra N. Mehrishi
Hans U. Lutz
Tony H. Merry
Gábor E. Tusnády
Show All
Source
Cite
Save
Citations (0)
1